Log In
BCIQ
Print this Print this
 

CD20

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting CD20

BCIQ
Print ChartPrint this
1 - Inflammation 7 - Cancer 1 - Autoimmune 2 - Cancer 1 - Autoimmune 1 - Inflammation 3 - Cancer 3 - Autoimmune 9 - Cancer 5 - Autoimmune 5 - Cancer 4 - Autoimmune 8 - Cancer 3 - Autoimmune 10 - Cancer 4 - Autoimmune 14 - Cancer 3 - Autoimmune 2 - Cancer 3 - Autoimmune
Phase of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIPhase IIIRegistrationApprovedMarketed
Autoimmune

3

3

4

3

4

5

3

1

1

Cancer

2

14

10

8

5

9

3

2

7

Inflammation

-

-

-

-

-

-

1

-

1




 Products Targeting CD20
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

25

$20,774.8M

$15,351.3M

$5,315.7M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today